France Scraps Order for Merck Antiviral Pill, Looks to Pfizer
- Health minister says molnupiravir studies were disappointing
- Pfizer’s Paxlovid is about to be approved, Olivier Veran said
This article is for subscribers only.
France canceled an order for Merck & Co.’s antiviral pill on disappointing test results and is now counting on a treatment from Pfizer Inc., according to the country’s health minister.
“We had to cancel because the last studies weren’t good,” Olivier Veran said Wednesday in an interview on BFM TV. “It cost us nothing.”